
Glisu M 2mg/500mg Tablet SR
Marketer
Biomarks Drugs India Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glisu M 2mg/500mg Tablet SR
DiabetaComb 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiabetaComb should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to evaluate blood cell counts and liver function.
Primary Ingredients of Glisu M 2mg/500mg Tablet SR
No text provided to rephrase.
Uses of Glisu M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glisu M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glisu M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Glisu M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glisu M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. Glisu M 2mg/500mg Extended-Release tablets should be taken with meals.
How Glisu M 2mg/500mg Tablet SR works:
Glisu M 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glisu M 2mg/500mg SR tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Glisu M 2mg/500mg SR tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any hazards before prescribing. Always seek medical advice.
Breast feedingUNSAFE
Extended-release Glisu M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glisu M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glisu M 2mg/500mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glisu M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Glisu M 2mg/500mg Tablet SR :
Should you forget a Glisu M 2mg/500mg SR tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glisu M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
